#Japan #Tokyo #Venture Fund #Alfresa #SBI Investment

Alfresa Corporation's Strategic Investment in SBI Venture Fund 2023 B

Alfresa Corporation, a subsidiary headquartered in Chiyoda, Tokyo, has made a significant investment in the "SBI Venture Fund 2023 B" operated by SBI Investment, a leading company responsible for nurturing new industries and investing in growth sectors. This strategic decision is aimed at enhancing the company's growth strategy and supporting innovation in various fields.

Background and Purpose

The Alfresa Group is implementing its growth strategy articulated in the "Alfresa Group Medium-Long Term Vision" aimed at fortifying its core and growth businesses while introducing new initiatives. The company is set to launch its second phase of the mid-term management plan "Vision 2032 Stage 2 – Pioneering the Future through Comprehensive Power" in April 2025. One of the management policies outlined in this strategy is to strategically invest in growth and new ventures to build a sustainable revenue model.

SBI Investment supports its portfolio companies with hands-on assistance, utilizing the vast network and management resources of the SBI Group. The SBI Venture Fund, one of Japan's largest venture capital funds, targets startups in innovative fields believed to be growth industries, both domestically and internationally.

Alfresa plays a pivotal role in pharmaceutical distribution, providing a wide range of products and services aimed at solving challenges in healthcare. Through this investment in the venture fund, the company aims to collaborate with startups focused on developing solutions in AI, big data, robotics, healthcare, and digital transformation (DX).

By leveraging the wealth of knowledge, expertise, and networks from SBI Investment's venture funding activities, Alfresa seeks to contribute to improving healthcare quality and enhancing operational efficiency in medical settings, while also establishing new revenue foundations.

Key Facts About the Fund and Investment

Overview of the Fund

• - The SBI Venture Fund 2023 B is designed to support innovative technologies and services.
• - Alfresa's investment marks a commitment to expanding its operational capabilities within the healthcare sector, particularly leveraging cutting-edge technologies.

Investment Details

1. Pre-Investment Holdings: 0
2. Investment Shares: 10
3. Commitment Amount: 1 billion yen (via a capital call method)
- This method allows investors to provide funds incrementally as requested by the fund's management.

Future Outlook

The impact of this investment on Alfresa's immediate performance is expected to be minimal. However, it is anticipated that in the medium to long term, this strategic move will significantly enhance the company's corporate value.

Alfresa is committed to updating stakeholders on any new developments regarding this investment, ensuring transparency and continued engagement.

This investment aligns with Alfresa's mission to innovate and lead in the healthcare sector, facilitating meaningful collaborations that address pressing societal needs through advanced solutions.